Table 1.
Characteristics of Patients Referred to CDI Clinica
| Characteristic | Value (N=211)b |
|---|---|
| Age (y) | 65 (18-93) |
| Sex: women | 140 (66.4) |
| Indication for referral | |
| Recurrent CDI | 199 (94.3) |
| First episode of CDI | 5 (2.4) |
| Nonspecific diarrhea | 7 (3.3) |
| Most common concurrent GI illness | |
| IBD | 16 (7.6) |
| IBS | 8 (3.8) |
| Microscopic colitis | 7 (3.3) |
| Previous CDI episodes | |
| 0 | 5 (2.4) |
| 1 | 18 (8.5) |
| 2 | 58 (27.5) |
| ≥3 | 130 (61.6) |
| CDI medications at presentation | |
| Vancomycin | 99 (46.9) |
| Metronidazole | 10 (4.7) |
| Fidaxomicin | 3 (1.4) |
| Vancomycin and metronidazole | 2 (0.9) |
| Loperamide | 1 (0.5) |
| Previous CDI medications | |
| ≥1 course of vancomycin | 168 (79.6) |
| ≥1 course of metronidazole | 149 (70.6) |
| ≥1 course of fidaxomicin | 31 (14.7) |
a
CDI = Clostridium difficile infection; GI = gastrointestinal tract; IBD = inflammatory bowel disease; IBS = irritable bowel syndrome.
b
Values are median (range) or No. of patients (%).